Meguid El Nahas

9.1k total citations · 3 hit papers
54 papers, 6.5k citations indexed

About

Meguid El Nahas is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Meguid El Nahas has authored 54 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Nephrology, 14 papers in Cardiology and Cardiovascular Medicine and 10 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Meguid El Nahas's work include Chronic Kidney Disease and Diabetes (34 papers), Dialysis and Renal Disease Management (21 papers) and Blood Pressure and Hypertension Studies (14 papers). Meguid El Nahas is often cited by papers focused on Chronic Kidney Disease and Diabetes (34 papers), Dialysis and Renal Disease Management (21 papers) and Blood Pressure and Hypertension Studies (14 papers). Meguid El Nahas collaborates with scholars based in United Kingdom, United States and Netherlands. Meguid El Nahas's co-authors include Bisher Kawar, Josef Coresh, Kai‐Uwe Eckardt, Andrew S. Levey, Paul E. de Jong, Bertram L. Kasiske, Kunihiro Matsushita, Ron T. Gansevoort, Brad C. Astor and Adeera Levin and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Meguid El Nahas

52 papers receiving 6.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report

2010 1.7k citations Meguid El Nahas et al. Kidney International profile →
Obesity and Diabetes in the Developing World — A Growing Challenge

2007 1.7k citations Meguid El Nahas et al. profile →
Chronic kidney disease as a global public health problem: Approaches and initiatives – a position statement from Kidney Disease Improving Global Outcomes

2007 1.1k citations Meguid El Nahas et al. Kidney International profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Meguid El Nahas United Kingdom	27	2.9k	1.2k	1.1k	915	782	54	6.5k
Tsuyoshi Watanabe Japan	43	2.3k 0.8×	1.3k 1.1×	1.3k 1.1×	896 1.0×	1.2k 1.5×	222	6.5k
Li Zuo China	28	4.0k 1.4×	1.3k 1.1×	815 0.7×	933 1.0×	854 1.1×	148	7.8k
Maarten W. Taal United Kingdom	45	3.4k 1.2×	1.5k 1.2×	738 0.7×	675 0.7×	615 0.8×	203	6.6k
Anna Köttgen Germany	39	2.9k 1.0×	834 0.7×	820 0.7×	984 1.1×	1.9k 2.4×	158	7.4k
Bénédicte Stengel France	44	3.8k 1.3×	1.3k 1.1×	643 0.6×	530 0.6×	466 0.6×	168	6.6k
Nilka Rı́os Burrows United States	38	1.9k 0.6×	775 0.6×	2.1k 1.9×	793 0.9×	446 0.6×	78	5.9k
Carmen A. Peralta United States	44	3.2k 1.1×	2.5k 2.0×	797 0.7×	661 0.7×	387 0.5×	158	6.9k
Luca De Nicola Italy	52	3.6k 1.2×	2.3k 1.9×	1.4k 1.3×	447 0.5×	613 0.8×	235	7.3k
Davide Bolignano Italy	38	2.8k 1.0×	1.0k 0.9×	766 0.7×	557 0.6×	970 1.2×	187	5.9k
Sylvia E. Rosas United States	41	2.0k 0.7×	1.2k 1.0×	2.2k 2.0×	452 0.5×	811 1.0×	120	6.3k

Countries citing papers authored by Meguid El Nahas

Since Specialization

Citations

This map shows the geographic impact of Meguid El Nahas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meguid El Nahas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meguid El Nahas more than expected).

Fields of papers citing papers by Meguid El Nahas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meguid El Nahas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meguid El Nahas. The network helps show where Meguid El Nahas may publish in the future.

Co-authorship network of co-authors of Meguid El Nahas

This figure shows the co-authorship network connecting the top 25 collaborators of Meguid El Nahas. A scholar is included among the top collaborators of Meguid El Nahas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meguid El Nahas. Meguid El Nahas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nahas, Meguid El, et al.. (2016). Renin-Angiotensin-Aldosterone system blockade in diabetic kidney disease: A critical and contrarian point of view. Saudi Journal of Kidney Diseases and Transplantation. 27(6). 1103–1103. 4 indexed citations

Fotheringham, James, Damian Fogarty, Meguid El Nahas, Michael J. Campbell, & Ken Farrington. (2015). The mortality and hospitalization rates associated with the long interdialytic gap in thrice-weekly hemodialysis patients. Kidney International. 88(3). 569–575. 52 indexed citations

Abdelhafiz, Ahmed H., et al.. (2014). Management of Diabetic Nephropathy in Older Patients: A Need for Flexible Guidelines. Postgraduate Medicine. 126(4). 171–177. 6 indexed citations

Fotheringham, James, Richard Jacques, Damian Fogarty, et al.. (2013). Variation in centre-specific survival in patients starting renal replacement therapy in England is explained by enhanced comorbidity information from hospitalization data. Nephrology Dialysis Transplantation. 29(2). 422–430. 17 indexed citations

Nahas, Meguid El, et al.. (2012). Urinary Matrix Metalloproteinase Activity in Diabetic Kidney Disease: A Potential Marker of Disease Progression. SHILAP Revista de lepidopterología. 2(1). 219–232. 27 indexed citations

Spasovski, Goce, Alberto Ortíz, Raymond Vanholder, & Meguid El Nahas. (2011). Proteomics in chronic kidney disease: The issues clinical nephrologists need an answer for. PROTEOMICS - CLINICAL APPLICATIONS. 5(5-6). 233–240. 14 indexed citations

Russell, Jennifer St. Clair, et al.. (2011). A study of the natural history of diabetic kidney disease (DKD). Nephrology Dialysis Transplantation. 27(5). 1847–1854. 95 indexed citations

Gonçalves, Anderson, et al.. (2011). Stopping Renin-Angiotensin System Inhibitors in Chronic Kidney Disease: Predictors of Response. Nephron Clinical Practice. 119(4). c348–c354. 8 indexed citations

Kopple, Joel D., Alfred K. Cheung, Jens Sandahl Christiansen, et al.. (2011). OPPORTUNITY : a large-scale randomized clinical trial of growth hormone in hemodialysis patients. Nephrology Dialysis Transplantation. 26(12). 4095–4103. 30 indexed citations

10.

Nahas, Meguid El. (2010). Cardio-Kidney-Damage: a unifying concept. Kidney International. 78(1). 14–18. 64 indexed citations

11.

Bello, Aminu K., Jean Peters, Jeremy Wight, & Meguid El Nahas. (2010). The Kidney Evaluation and Awareness Program in Sheffield (KEAPS): A Community-Based Screening for Microalbuminuria in a British Population. Nephron Clinical Practice. 116(2). c95–c103. 11 indexed citations

12.

Køber, Lars, et al.. (2010). Cardiovascular Effects of Growth Hormone in Adult Hemodialysis Patients: Results from a Randomized Controlled Trial. Nephron Clinical Practice. 115(3). c213–c226. 5 indexed citations

13.

Feldt‐Rasmussen, Bo & Meguid El Nahas. (2009). Potential Role of Growth Factors With Particular Focus on Growth Hormone and Insulin-Like Growth Factor-1 in the Management of Chronic Kidney Disease. Seminars in Nephrology. 29(1). 50–58. 9 indexed citations

14.

Goyder, Elizabeth, et al.. (2008). CKD and Poverty: A Growing Global Challenge. American Journal of Kidney Diseases. 53(1). 166–174. 109 indexed citations

15.

Kopple, Joel D., Alfred K. Cheung, Jens Sandahl Christiansen, et al.. (2008). OPPORTUNITY™. Clinical Journal of the American Society of Nephrology. 3(6). 1741–1751. 25 indexed citations

16.

Feldt‐Rasmussen, Bo, Martin Lange, Władysław Sułowicz, et al.. (2007). Growth Hormone Treatment during Hemodialysis in a Randomized Trial Improves Nutrition, Quality of Life, and Cardiovascular Risk. Journal of the American Society of Nephrology. 18(7). 2161–2171. 79 indexed citations

17.

McKee, Kevin, et al.. (2005). The quality of life of older and younger people who receive renal replacement therapy. Ageing and Society. 25(6). 903–923. 9 indexed citations

18.

Dirks, John H., Dick de Zeeuw, Sanjay Kumar Agarwal, et al.. (2005). Prevention of chronic kidney and vascular disease: Toward global health equity—The Bellagio 2004 Declaration. Kidney International. 68(98). S1–S6. 89 indexed citations

19.

Nahas, Meguid El. (2005). The global challenge of chronic kidney disease. Kidney International. 68(6). 2918–2929. 131 indexed citations

20.

White, Kathryn, Rudolf W. Bilous, Sally M. Marshall, et al.. (2002). Podocyte Number in Normotensive Type 1 Diabetic Patients With Albuminuria. Diabetes. 51(10). 3083–3089. 257 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact